FDMT
4D Molecular Therapeutics, Inc.
+0.67 (+4.83%)14.43USD312K成交股數718M市值–本益比(近四季)7.8股價營收比+25106.7%營收年增(近四季)2026-11-10下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 3.8M+26907% | 3.0M+304600% | 90K+2900% | 15K+200% | 14K-50% | 1K-100% | 3K-99% | 5K-98% | 28K | 20.2M | 239K | 298K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 68.3M | 65.0M | 49.4M | 48.0M | 40.7M | 43.1M | 38.5M | 31.9M | 27.9M | 25.1M | 23.6M | 22.4M |
| 銷售管理費用 | 12.5M | 11.7M | 11.8M | 11.5M | 12.9M | 13.0M | 12.7M | 10.6M | 10.3M | 9.1M | 8.8M | 8.0M |
| 營業利益 | −77.0M+44% | −73.6M+31% | −61.2M+20% | −59.5M+40% | −53.6M+41% | −56.1M+302% | −51.1M+59% | −42.5M+41% | −38.1M | −14.0M | −32.1M | −30.1M |
| 營業利益率 | -2,037.2% | -2,416.1% | -67,983.3% | -396,373.3% | -383,007.1% | -5,611,700.0% | -1,704,400.0% | -849,120.0% | -136,200.0% | -69.2% | -13,446.0% | -10,102.7% |
| 稅後淨利 | −72.9M+52% | −68.8M+38% | −56.9M+30% | −54.7M+56% | −48.0M+48% | −49.7M+384% | −43.8M+48% | −35.0M+22% | −32.4M | −10.3M | −29.6M | −28.7M |
| 淨利率 | -1,929.0% | -2,256.6% | -63,195.6% | -364,386.7% | -342,657.1% | -4,967,100.0% | -1,461,433.3% | -699,060.0% | -115,717.9% | -50.8% | -12,391.6% | -9,624.8% |
| 稀釋 EPS | -1.04+21% | -1.01+12% | -1.01+28% | -0.98+56% | -0.86+30% | -0.90+275% | -0.79+3% | -0.63-28% | -0.66 | -0.24 | -0.77 | -0.88 |
| 稀釋股數 | 70.3M | 68.1M | 56.1M | 55.9M | 55.7M | 53.9M | 55.6M | 55.3M | 49.3M | 42.3M | 38.3M | 32.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 70.4M | 72.5M | 48.6M | 77.2M | 134M | 149M | 188M | 189M | 276M | 276M | 236M | 78.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 493M | 513M | 424M | 474M | 516M | 560M | 604M | 620M | 630M | 362M | 353M | 244M |
| 有息負債 | 19.6M | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 85.0M | 61.1M | 55.0M | 52.7M | 46.0M | 49.8M | 51.1M | 31.8M | 29.3M | 31.7M | 27.4M | 25.4M |
| 股東權益 | 408M | 452M | 369M | 421M | 470M | 511M | 553M | 588M | 601M | 330M | 325M | 219M |
| 負債比 | 17.2% | 11.9% | 13.0% | 11.1% | 8.9% | 8.9% | 8.5% | 5.1% | 4.7% | 8.8% | 7.8% | 10.4% |
| 淨現金(現金 − 有息負債) | 50.8M | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −68.1M | – | – | −47.8M+64% | – | – | – | −29.1M | – | – | −27.9M |
| 資本支出 | – | – | – | – | 631K | – | – | – | 710K | – | – | 1.0M |
| 自由現金流 | – | – | – | – | −48.4M+62% | – | – | – | −29.8M | – | – | −28.9M |
| 折舊攤銷 | – | 1.3M | – | – | 1.1M | – | – | – | 1.2M | – | – | 1.0M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | -345,635.7% | – | – | – | -106,421.4% | – | – | -9,704.0% |
營收拆解 2021 年度 10-K 的分部揭露 · 年增對前一年度
地區2021 年度 · 18.0M
| 瑞士 | 17.2M | 95.2% | +33.2% |
|---|---|---|---|
| 荷蘭 | 736K | 4.1% | -0.8% |
| 美國 | 121K | 0.7% | – |
產品／服務2021 年度 · 18.0M
| Collaboration And License Revenue | 18.0M | 100.0% | +32.5% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 85.2M | +230194.6% | −140M | -164.4% | -2.42 | −110M |
| FY2024 | 37K | -99.8% | −161M | -434,778.4% | -2.98 | −138M |
| FY2023 | 20.7M | +562.3% | −101M | -486.6% | -2.58 | −78.6M |
| FY2022 | 3.1M | -82.7% | −107M | -3,435.4% | -3.32 | −98.2M |
| FY2021 | 18.0M | +35.0% | −71.3M | -395.4% | -2.57 | −78.2M |
| FY2020 | 13.4M | +92.0% | −56.7M | -424.3% | -8.82 | −51.9M |
| FY2019 | 7.0M | – | −49.3M | -708.4% | -9.59 | −39.9M |